287 related articles for article (PubMed ID: 31440463)
21. Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs).
Ozsvari B; Sotgia F; Simmons K; Trowbridge R; Foster R; Lisanti MP
Oncotarget; 2017 Oct; 8(45):78340-78350. PubMed ID: 29108233
[TBL] [Abstract][Full Text] [Related]
22. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
Lamb R; Ozsvari B; Lisanti CL; Tanowitz HB; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Mar; 6(7):4569-84. PubMed ID: 25625193
[TBL] [Abstract][Full Text] [Related]
23. "Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy.
Fiorillo M; Sotgia F; Lisanti MP
Front Oncol; 2018; 8():677. PubMed ID: 30805301
[TBL] [Abstract][Full Text] [Related]
24. Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study.
Scatena C; Roncella M; Di Paolo A; Aretini P; Menicagli M; Fanelli G; Marini C; Mazzanti CM; Ghilli M; Sotgia F; Lisanti MP; Naccarato AG
Front Oncol; 2018; 8():452. PubMed ID: 30364293
[No Abstract] [Full Text] [Related]
25. Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells.
Schibler J; Tomanek-Chalkley AM; Reedy JL; Zhan F; Spitz DR; Schultz MK; Goel A
PLoS One; 2016; 11(11):e0167323. PubMed ID: 27902770
[TBL] [Abstract][Full Text] [Related]
26. Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.
De Francesco EM; Maggiolini M; Tanowitz HB; Sotgia F; Lisanti MP
Oncotarget; 2017 Aug; 8(34):56126-56142. PubMed ID: 28915578
[TBL] [Abstract][Full Text] [Related]
27. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.
Lamb R; Fiorillo M; Chadwick A; Ozsvari B; Reeves KJ; Smith DL; Clarke RB; Howell SJ; Cappello AR; Martinez-Outschoorn UE; Peiris-Pagès M; Sotgia F; Lisanti MP
Oncotarget; 2015 Jun; 6(16):14005-25. PubMed ID: 26087309
[TBL] [Abstract][Full Text] [Related]
28. A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.
Sotgia F; Ozsvari B; Fiorillo M; De Francesco EM; Bonuccelli G; Lisanti MP
Cell Cycle; 2018; 17(17):2091-2100. PubMed ID: 30257595
[TBL] [Abstract][Full Text] [Related]
29. Dendritic Polyglycerol-Conjugated Gold Nanostars for Metabolism Inhibition and Targeted Photothermal Therapy in Breast Cancer Stem Cells.
Pan Y; Zhou S; Liu C; Ma X; Xing J; Parshad B; Li W; Wu A; Haag R
Adv Healthc Mater; 2022 Apr; 11(8):e2102272. PubMed ID: 34990518
[TBL] [Abstract][Full Text] [Related]
30. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
Front Oncol; 2018; 8():203. PubMed ID: 29922594
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
[TBL] [Abstract][Full Text] [Related]
32. MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.
Sancho P; Burgos-Ramos E; Tavera A; Bou Kheir T; Jagust P; Schoenhals M; Barneda D; Sellers K; Campos-Olivas R; Graña O; Viera CR; Yuneva M; Sainz B; Heeschen C
Cell Metab; 2015 Oct; 22(4):590-605. PubMed ID: 26365176
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy.
Praharaj PP; Panigrahi DP; Bhol CS; Patra S; Mishra SR; Mahapatra KK; Behera BP; Singh A; Patil S; Bhutia SK
Cancer Lett; 2021 Feb; 498():217-228. PubMed ID: 33186655
[TBL] [Abstract][Full Text] [Related]
34. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells.
Shen YA; Chen CC; Chen BJ; Wu YT; Juan JR; Chen LY; Teng YC; Wei YH
Cells; 2021 Jul; 10(7):. PubMed ID: 34359941
[TBL] [Abstract][Full Text] [Related]
35. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy.
Kaur J; Bhattacharyya S
Front Oncol; 2021; 11():756888. PubMed ID: 34804950
[TBL] [Abstract][Full Text] [Related]
36. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
Gao C; Shen Y; Jin F; Miao Y; Qiu X
PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
[TBL] [Abstract][Full Text] [Related]
37. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors.
Muller C; Lacroix-Malgras V; Kluza J; Laine W; Güler Y; Bost F; Boisbrun M; Mazerbourg S; Flament S
Cancer Cell Int; 2024 Apr; 24(1):132. PubMed ID: 38594745
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria as therapeutic targets for cancer stem cells.
Song IS; Jeong JY; Jeong SH; Kim HK; Ko KS; Rhee BD; Kim N; Han J
World J Stem Cells; 2015 Mar; 7(2):418-27. PubMed ID: 25815125
[TBL] [Abstract][Full Text] [Related]
39. Metformin and prostate cancer stem cells: a novel therapeutic target.
Mayer MJ; Klotz LH; Venkateswaran V
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cell metabolism: target for cancer therapy.
Chae YC; Kim JH
BMB Rep; 2018 Jul; 51(7):319-326. PubMed ID: 29764565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
